Novel Therapeutics
for Hair Regrowth

The Science: A Nature-inspired Approach to Regrowing Your Own Hair

About Us

Developing novel treatments to address androgenic alopecia.

Amplifica is a biopharmaceutical company focused on developing novel treatments to address androgenic alopecia (hair loss), a condition estimated to affect over 50 million men and over 30 million women in the United States alone. The Company has identified and isolated unique signaling molecules that stimulate hair follicles to regrow hair. Amplifica will be initiating clinical trials to evaluate the safety and efficacy of its core technology as well as obtaining all applicable regulatory approvals.


Amplifica’s Science Based Approach.

Hair regrowth

Amplifica’s approach to hair regrowth is based on the discovery of naturally occurring signaling molecules that affect new hair growth.

Molecular biology

The scientific studies leading to the discovery of these molecules are based on the unique molecular biology found in the naturally occurring hairy nevi or “hairy moles” which has been extensively studied and uniquely understood by Amplifica.

Our Team

Meet the Amplifica Leadership Team.

Frank Fazio

President &
Chief Executive

Wajdie Ahmad

Executive Chairman

Maksim Plikus, PhD

Co-Founder &
Chief Scientific

William Rassman, MD

Co-Founder &
Chief Medical

Board of Directors

Meet the Amplifica Board of Directors.

Executive Chairman, Co-Founder and Chief Operating Officer

Director, President and Chief Executive Officer





News and Publications

Read our latest news.

Contact Us

Get in touch.

    Go to Top